Median Technologies to participate in the Cowen and Company 39th Annual Health Care Conference in Boston
Press release – For immediate release – 5:45 pm CET
Median Technologies, The Imaging Phenomics Company® (Paris: ALMDT), will be participating in the Cowen and Company 39th Annual Health Care Conference on Wednesday, March 13, 2019 in Boston. Fredrik Brag, Median’s Chairman, CEO and Co-founder will present at 9:20 am Eastern Time.
Webcast and presentation will be available on the Investors section of Median’s website.
About Median Technologies
Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and iBiopsy®, our AI-powered software as medical device help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.
Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label “Innovative company” by the BPI and is listed on Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME), is part of the Enternext® PEA-PME 150 index and has been awarded the Euronext European Rising Tech label. For more information: www.mediantechnologies.com
Head of Corporate Marketing and Financial Communications
+33 6 10 93 58 88
+33 6 21 10 49 24
Alizé RP (Press)
+33 6 64 18 99 59